KEYTRUDA Padcev MIBC Survival: New Era in Treat...

By HEOR Staff Writer

March 2, 2026

KEYTRUDA Padcev MIBC Survival Breakthrough in Cisplatin-Eligible Patients KEYTRUDA Padcev MIBC Survival benefits shone in the Phase 3 KEYNOTE-B15 trial, where...
Novo Nordisk Announces Semaglutide Price Reduction to Improve Patient Access
NICE Approves Ruxolitinib Cream for Treating Vitiligo with Facial Involvement
Administrative Court Error Complicates Infarmed Vaccine Data Transparency
Enhancing Safety and Performance: The Role of EU Medical Device Panels
Genotype ECG Prediction
NICE Endorses Pegzilarginase for Treating Arginase Deficiency
Late-Breaking Data on Bladder Cancer Treatments from KEYNOTE-B15 Trial
Robotic Surgery Portugal: A Landmark Achievement at ULS Viseu Dão-Lafões
Pharmaceutical Tender Investigation Sparks Regulatory Scrutiny in South Africa
Advancements in Uncertainty-Aware Diagnostics with ConfiDx LLM
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
National HealthTech Access: Transforming NHS Adoption and Equity